ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03738397

Public ClinicalTrials.gov record NCT03738397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis

Study identification

NCT ID
NCT03738397
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
673 participants

Conditions and interventions

Interventions

  • Dupilumab Biological
  • Placebo to dupilumab Drug
  • Placebo to upadacitinib Drug
  • Upadacitinib Biological

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 76 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2019
Primary completion
Aug 26, 2020
Completion
Dec 8, 2020
Last update posted
Mar 14, 2024

2019 – 2020

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
46
Facility City State ZIP Site status
Clinical Research Center AL /ID# 210277 Birmingham Alabama 35209-6802
University of Arkansas for Medical Sciences /ID# 211688 Little Rock Arkansas 72205
Tien Q Nguyen MD, Inc /ID# 208934 Fountain Valley California 92708-3701
UCSF Fresno /ID# 213253 Fresno California 93701-2302
Jonathan Corren, MD. INC /ID# 208987 Los Angeles California 90025-4749
California Allergy and Asthma Medical Group /ID# 213680 Los Angeles California 90025-7014
Dermatology Research Associates /ID# 209097 Los Angeles California 90045
Los Angelos Cataract Center /ID# 208524 Los Angeles California 90056
Dermatology Clinical Trials /ID# 214622 Newport Beach California 92660-7853
UC Davis Health /ID# 209285 Sacramento California 95816
Ucsd /Id# 208990 San Diego California 92103
Clinical Science Institute /ID# 211022 Santa Monica California 90404-2102
The Community Research of South Florida /ID# 211145 Hialeah Florida 33016-1897
Miami Dermatology and Laser Institute /ID# 212938 Miami Florida 33173-3570
Florida International Rsrch cr /ID# 211562 Miami Florida 33173
Progressive Medical Research /ID# 211994 Port Orange Florida 32127
GCP Research /ID# 216020 St. Petersburg Florida 33705
Clinical Research Trials of Florida, Inc. /ID# 210751 Tampa Florida 33607
Integrated Clinical Research LLC /ID# 208831 West Palm Beach Florida 33406-6063
Georgia Pollens Clinical Research Centers, Inc /ID# 211092 Albany Georgia 31707-1282
Meridian Clinical Research Dermatology /ID# 213251 Savannah Georgia 31406-2632
Northwestern University Feinberg School of Medicine /ID# 208680 Chicago Illinois 60611-2927
Medical Dermatology Associates of Chicago /ID# 210265 Chicago Illinois 60654-6903
Sneeze, Wheeze, & Itch Associates, LLC /ID# 212058 Normal Illinois 61761
Dawes Fretzin, LLC /ID# 209187 Indianapolis Indiana 46256
Beacon Clinical Research, LLC /ID# 209280 Quincy Massachusetts 02169
Clarkston Skin Research /ID# 208739 Clarkston Michigan 48346
Henry Ford Health System /ID# 208741 Detroit Michigan 48202
Clinical Research Institute, Inc /ID# 210852 Minneapolis Minnesota 55402-2606
Allergy, Asthma & Immunology Associates, PC /ID# 213481 Lincoln Nebraska 68505-2343
Skin Specialists, PC /ID# 208843 Omaha Nebraska 68144
Dartmouth-Hitchcock Medical Center /ID# 213727 Lebanon New Hampshire 03756
Forest Hills Dermatology Group /ID# 209249 Kew Gardens New York 11415
Montefiore Medical Center /ID# 209647 The Bronx New York 10467
Wake Forest Univ HS /ID# 208892 Winston-Salem North Carolina 27157
Univ Hosp Cleveland /ID# 208852 Cleveland Ohio 44106
The Ohio State University /ID# 209254 Columbus Ohio 43210-1257
Southside Dermatology /ID# 212004 Tulsa Oklahoma 74132
Oregon Medical Res Center PC /ID# 208807 Portland Oregon 97223
Oregon Health and Science University /ID# 208809 Portland Oregon 97239
Medical University of South Carolina /ID# 211054 Charleston South Carolina 29425
Clinical Research Solutions, LLC /ID# 212542 Jackson Tennessee 38305-2163
Orion Clinical Research /ID# 208765 Austin Texas 78759-4100
DiscoveResearch, Inc. /ID# 213171 Bryan Texas 77802
Epiphany Dermatology - Fort Worth /ID# 211187 Fort Worth Texas 76244-6548
Sante Clinical Research /ID# 212970 Kerrville Texas 78028-9640
Stephen Miller, MD PA /ID# 210071 San Antonio Texas 78249
Sugar Land Allergy, Asthma, and Immunology Center /ID# 211153 Sugar Land Texas 77479-3153
University of Utah /ID# 209001 Salt Lake City Utah 84112-5500
Clinical Research Partners, LLC /ID# 212262 Richmond Virginia 23220-4459
Premier Clinical Research /ID# 212142 Spokane Washington 99202
West Virginia Research Inst /ID# 212730 South Charleston West Virginia 25309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03738397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2024 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03738397 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →